Paratek Pharma Inc
(PRTK)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Sales | 160,268 | 130,162 | 46,924 | 16,544 | 17,117 |
| Cost of Goods | 23,056 | 21,535 | 8,651 | 3,484 | N/A |
| Gross Profit | 137,212 | 108,627 | 38,273 | 13,060 | 17,117 |
| Operating Expenses | 183,477 | 150,292 | 114,428 | 129,173 | 121,202 |
| Operating Income | -46,209 | -41,130 | -75,504 | -115,629 | -104,085 |
| Interest Expense | 18,119 | 17,408 | 20,240 | 16,403 | 10,985 |
| Other Income | 819 | 54 | -797 | 3,543 | 3,216 |
| Pre-tax Income | -63,509 | -58,484 | -96,541 | -128,489 | -111,854 |
| Income Tax | 57 | 600 | N/A | 301 | 502 |
| Net Income Continuous | -63,566 | -59,084 | -96,541 | -128,790 | -112,356 |
| Net Income | $-63,566 | $-59,084 | $-96,541 | $-128,790 | $-112,356 |
| EPS Basic Total Ops | -1.17 | -1.22 | -2.19 | -3.93 | -3.57 |
| EPS Basic Continuous Ops | -1.17 | -1.22 | -2.19 | -3.93 | -3.57 |
| EPS Diluted Total Ops | -1.17 | -1.22 | -2.19 | -3.93 | -3.57 |
| EPS Diluted Continuous Ops | -1.17 | -1.22 | -2.19 | -3.93 | -3.57 |
| EPS Diluted Before Non-Recurring Items | -1.17 | -1.22 | -2.14 | -3.93 | -3.57 |
| EBITDA(a) | $-45,719 | $-40,739 | $-74,926 | $-116,921 | $-105,151 |